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Abstract
This thesis centres on cancer of the retromolar triangle (RMT), an uncommon head and neck 
cancer. The retromolar trigone area is the region within the oral cavity defined by the 
American Joint Committee on Cancer (AJCC) as the attached mucosa overlying the 
ascending ramus of the mandible from the level of the posterior surface of the last molar 
tooth to the apex superiorly, adjacent to the tuberosity of the maxilla. The main points of 
significance about this area are that diagnosis may be delayed, the region is less accessible, 
and reconstruction is somewhat more difficult. Review of the literature revealed that there is 
a paucity of information regarding factors affecting diagnosis, treatment and prognosis of 
RMT cancer. The aim of this study was to assess the anatomy of the RMT and the pathology 
and natural history of cancer in this area to evaluate the present strategies for treatment.
Gross cadaveric dissections were performed in the RMT on both sides of the oral cavity to 
examine the normal anatomy and to identify anatomical structures that could possibly be 
affected by excisional surgery. Structures liable to damage were the lingual nerve, the 
inferior alveolar nerve, the buccal nerve, the palatoglossus muscle, the medial pterygoid 
muscle, the insertion of the temporalis muscle and less frequently the submandibular duct. 
Damage to these structures could affect sensation, speech, swallowing and chewing.
The medical records of 113 patients with histologically proven squamous cell carcinoma of 
the RMT, treated at Camiiesburn Hospital, Glasgow, between 1985 and 1999, were reviewed 
retrospectively in order to study the natural history of the disease. The male; female ratio 
was 2.2:1 and the average age was 65 years. A total of 9.7% of patients were clinically 
staged as T l, 41.6% were T2, 16% were T3 and 32.7% were T4. At presentation 71 patients 
(63%) had a clinically negative neck, while 85 patients (75%) had a neck dissection at the 
time of treatment of the primary. A comparison between the clinical and pathological T and 
N stages highlighted the difficulties of clinical TNM staging with upstaging of the primary T
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stage in 15.5% of patients and downstaging in 11% and upstaging of neck disease in 21% 
and downstaging in 9%.
Despite advances in treatment, this series has shown no significant improvement in survival 
over the 15-year study period. The determinant 5-year survival rates by the Kaplan-Meier 
method were pTl: 75%, pT2: 40%, pT3; 47%, pT4: 32% and overall 42%. In total 34% of 
patients died of disease directly related to their retromolar trigone cancer and this included 
12% with systemic failure. Loco-regional failure of the retromolar trigone cancer accounted 
for death in 21%.
The understanding of the retromolar trigone tumours as a separate entity from other intraoral 
squamous cell carcinomas should allow us to formulate different strategies for its treatment 
in the future.
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Introduction
Retromolar trigone (RMT) cancer is an uncommon head and neck cancer. The retromolar 
trigone area is the region within the oral cavity overlying the ascending ramus of the 
mandible from the level of the posterior surface of the last molar tooth to the apex 
superiorly, adjacent to the tuberosity of the maxilla.
Due to the small size of the retromolar trigone, tumors arising here usually involve the 
adjacent anterior tonsillar pillar, tonsillar fossa, or soft palate. Distinguishing a single site of 
origin is often impossible. Diagnosis may be delayed since tumor may remain dormant for 
quite some time until the patient becomes symptomatic. In most cases, the primary 
presenting symptom is pain that is worsened by chewing. Other symptoms include referred 
otalgia and trismus.
Nearly all of these cancers are squamous cell carcinomas. In early disease (Stages I and II) 
surgery or radiation alone with elective neck treatment (secondary to the tendency for 
regional nodal spread) is most often utilized. For advanced stages, multimodality therapy 
with surgery and postoperative radiation is often used. Another point of significance about 
this area is that, the region is less accessible and surgical excision and reconstmction is 
somewhat more difficult.
A review of the medical literature was performed by using OVID/Medline and PubMed 
search strategies. Keywords entered included retromolar trigone, intraoral squamous cell 
carcinoma, natural history, recurrence, survival. Review of the literature revealed that there 
is a paucity of information regarding factors affecting diagnosis, treatment and prognosis of 
the RMT cancer. The aim of this study was to assess all these factors by looking into the 
anatomy of the area, the pathology of the cancer and the natural history of the disease. This 
would ultimately lead to an evaluation of the present strategies in treatment.
11
Literature review
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Anatomy
The retromolar trigone is part of the oral cavity (Figure 1). The oral cavity is defined as the 
region that extends from the skin-vermilion junction of the lips to the junction of the hard 
and soft palate above and to the line of the circumvallate papillae below. The anterior 
tonsillar pillar or palatoglossal arch is the lateral border between the oral cavity and the 
oropharynx.
Hard Palate
Soft Palate
Buccal mucosa
Tonsil
Retromolar Trigone
Tongue
Floor of Mouth
Figure 1 Anatomy of the oral cavity.
The retromolar trigone is a poorly defined area covered under the terms “posterior floor of 
the mouth,” “posterior alveolus,” and “anterior tonsillar pillar”. Bertelli in 1915 described 
the “area” as the “retromolar space”, being the portion joining the two alveolar borders, 
superior and inferior, as well as parts of these borders that lie behind the roots of the last 
molar teeth (1). Barbosa in 1959 used the term retromolar “area” rather than “region”, seeing 
that it lacks definite anatomical limits, as the part of the buccal cavity which lies between the
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two dental arcades on either side and behind the roots of the last molar teeth, and which 
establishes a communication between the medial and vestibular portions of the buccal cavity 
when the dental arcades lie in contact (2).
The definition used mostly nowadays comes from the American Joint Committee on Cancer 
(AJCC): “Retromolar Gingiva (Retromolar Trigone or Pterygomandibular Raphe) (ICD-0 
145.6). This is the attached mucosa overlying the ascending ramus of the mandible from the 
level of the posterior surface of the last molar tooth to the apex superiorly, adjacent to the 
tuberosity of the maxilla” (3).
Coronoid p ro cess
B ase of mandible
/ Ramu&
Angle 
Oblique line
Figure 2 Retromolar Trigone (blue shadowed area) on the mandible. (From Netter FH: 
Interactive Atlas of Human Anatomy, Ciba-Geigy, 1995. Modified by the author)
The definition of the triangle is as following: the distal surface of the last lower molar tooth 
forms the base, the maxillary tuberosity forms the apex, the upward extension of the oblique 
line of the mandible to the coronoid process forms the triangle’s lateral side, and a line 
connecting the distal lingual cusp of the last molar and the coronoid process forms the 
medial side. The triangle’s base is continuous laterally with the gingivobuccal sulcus and
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medially the gingivolingual sulcus. The triangle’s lateral side is continuous with the buccal 
mucosa, and the medial side blends into the anterior tonsillar pillars (Figure 2 & Figure 3).
Retrom olar glands
Palatopnaryngeus m uscle 
Palatine tonsil
Pterygoid ham ulus
Buccinator m uscle
Pterygom andibular raphe
Superior pharyngeal 
constric to r m uscle
Palatog lossus m uscle
Figure 3 Anatomy of the retromolar trigone (blue shadowed area). (From Netter FH: 
Interactive Atlas of Human Anatomy, Ciba-Geigy, 1995. Modified by the author)
The mucosa of RMT as the rest of the oral cavity is lined by stratified squamous epithelium. 
The underlying submucosa contains minor salivary glands. The thickness of the mucosa 
over the RMT is considerably thicker (4.03±1.15mm on average) compared to the rest of the 
oral mucosa (0.5-1.5mm range) (4;5). It is flaccid like the buccal mucosa, being greatly 
mobile and elastic at the angle joining the two alveolar arcades. It lies over the 
pterygomanbibular raphe, which links the buccinator muscle and the superior constrictor of 
the pharynx. The buccopharyngeal fascia lies immediately below the buccinator muscle and 
the superior constrictor of the pharynx and separates them from the buccal pad of fat. By 
following this pad the deep structures of the RMT are visualized. Laterally lie the masseter
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muscle and the anterior border of the ascending ramus, almost all of which is invested by the 
tendinous insertion of the temporalis muscle (Figure 4).
Hoiizoiital Section - Siipeiior View
0
B uccinator m uscle
Buccopharyngeal fa sc ia
Facial artery  and vein
Pterygom andibular raphe
Lingual nerve  and superior 
pharyngeal constrictor m usci
M asse te r m uscle
Ram us of mandible
Inferior a lveolar 
a rte ry , vein and nerve
Medial 
pterygoid
R etrom andibular vein
Palatoglossus m uscle 
in palatoglossal arch 
Palatine tonsil
Palatopharyngeus m uscle  in 
pala topharyngeal arch
Buccopharyngeal ra sc ia  and 
retropharyngeal sp ace
Sectioned below lingula of mandible
Figure 4 Horizontal section of the mouth (retromolar trigone: blue shadowed area). (From 
Netter FH: Interactive Atlas of Human Anatomy, CIba-Gelgy, 1995. Modified by the author)
Crossing this border is the buccal nerve. Medially lies the anterior edge of the medial 
pterygoid muscle. In the acute deep angle formed by the medial pterygoid and the ascending 
ramus, which is open superiorly, run the two branches of the mandibular nerve - the inferior 
alveolar and the lingual nerve (Figure 5). These three nerves -  the buccal, inferior alveolar 
and lingual -  are all sensory and easily accessible to cancerous infiltration from the 
retromolar area, explaining the painful symptomatology of these tumors (2). Furthermore, 
the anatomical variations of the position of the lingual nerve, which can be above the lingual
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crest (14.5%) or even into the retromolar area (0.15%), makes it vulnerable to the usually 
required margins of tumour excision (6).
Inferior alveolar nerve
I Deep tendon 
Temporal muscle Superficial I tendon
Buccal nerve
Buccinator muscle (cut) 
Lingual nerve 
Medial pterygoid muscle
Figure 5 Vulnerable nerves at the retromolar trigone. (Modified from SIcher and Dubrul: 
Anatomy of Local Anesthesia. In: Oral anatomy)
The buccal pad of fat passes into the pterygomandibular angle, ascends to the zygomatic or 
infratemporal fossa, and occupies the free space between the pterygoid and temporalis 
muscles; it surfaces at the lower limit of the temporal fossa enclosing the anterior border of 
the temporalis muscle. It is along the weak fatty tissue of this pad of fat that the deeper layer 
of the area passes through the complicated planes of the zygomatic and pterygomaxillary 
fossae and to the inferior part of the temporal fossa. This fact explains the pattern of deep 
infiltration of retromolar tumors reaching and including the deep spaces of the tonsillar and 
prestyloid pharyngeal space, seeing that all these spaces intercommunicate amply(2).
The blood supply is from the tonsillar and ascending palatine branches of the facial artery, 
with contributions from the dorsal lingual, ascending pharyngeal, and lesser palatine arteries
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(Figure 6). Venous drainage is through the tonsillar bed to the pharyngeal plexus of veins 
and to the common facial vein (7;8) (Figure 7).
Buccinator m uscle  
and parotid duct (cu t)
Inferior alveo lar a rte ry  and lingual
Superior pharyngeal constric tor m uscle 
lufaxillary artery
A scending pharyngeal artery  
Tonsillar artery
A scending palatine artery
Facial a rte ry
Ascending pharyngeal artery
Figure 6 Arteries of Oral and Pharyngeal Regions. (From Netter FH: Interactive Atlas of 
Human Anatomy, Ciba-Geigy, 1995. Modified by the author)
18
fr/taxillary veins
Retrom andibular vein
Inferior a lveolar vein and artery  
Extemal jugular vein (cut)
Common trunk fo r facial, 
retrom andibular and lingual veins 
Intemal jugular vein
Figure 7 Veins of Oral and Pharyngeal Regions. (From Netter FH: Interactive Atlas of Human 
Anatomy, Ciba-Geigy, 1995. Modified by the author)
The sensory innervation of the RMT is from branches of the glossopharyngeal (IX) and of 
the lesser palatine (V2) nerve (Figure 8). The contribution of the IX cranial nerve accounts 
for the referred ear pain that may be observed in patients with cancer arising in this area 
(Figure 9).
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Afferent ûmeiTation of Mouth iiiid Phiii^iix 
.Aiiteiioi View
G lossophazynccal ne 
F ecin l ner«
Trigem inal (V)(maxiMary) 
Via superior alveolar nerves
V4a pterygopalatine 
ganglion and greater and 
le sse r palatine nerves
V igus (X)
Via internal branch of 
superior laryngeal nerve
rveOX)
0 0 :%
Facial (V ll)(nervus in te rm e d iu s)
Via greater petrosal nerve, 
pterygopalatine ganglion 
and greater and le sser 
palatine nerves
G losso p h a ry n g ea l (IX)
Via pharyngé^ plexus 
Via tonsillar branches
Taste plus general sensation 
via lingual branches
Figure 8 Innervation of mouth and pharynx. (From Netter FH: Interactive Atlas of Human 
Anatomy, Ciba-Geigy, 1995. Modified by the author)
Figure 9 Neural pathways for referred otalgia. A. From floor of mouth and anterior tongue. B. 
From posterior tongue, oropharynx, and pharynx. (From Lingeman RE and Singer Ml: 
Evaluation of the patient with head and neck cancer. In: Cancer of the Head and Neck. 
Edited by Suen J and Myers E. New York, Churchill Livingstone, 1981)
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The lymphatic drainage of the retromolar trigone is similar to that of the tonsillar fossa, 
passing to the upper deep jugular chain of lymph nodes. Some lymph channels may also end 
in the submandibular, in the subparotid and in the lateral retropharyngeal lymph nodes 
(Figure 10).
Superficial parotid nodes (deep 
parotid nodes deep  to  parotid gland
Subparotid node
Facial nodes 
(buccal nodes)
lubndibular and 
subm andibular nodes
Subm ental nodes
Suprahyoid node 
Superior thyroid nodes
Anterior deep  cervical (pretracheal and 
thyroid) nodes (deep to  s trap  m u sc le s )
Anterior superficial cervical 
nodes (anterior jugular n odes)
Mastoid nodes
Occipital nodes
Stem ocleidom astoid nodes
Extemal jugular node (lateral 
superficial cerv ical node)
Jugulodigastric node
Deep lateral nodes (spinal 
a c c e ss o ry  n odes)
Intercalated node
Intemal jugular chain of nodes 
(deep lateral cerv ical no d es)
Inferior deep cerv ical (sca len e ) node
-Transverse cerv ical chain of nodes
Juguloom ohyoid node 
Supraclavicular nodes
Thoracic duct
Jugu lar trunk
Subclavian trunk and 
node of subclav ian  chain
Figure 10 Lymph Vessels and Nodes of Oral and Pharyngeal Regions. (From Netter FH: 
Interactive Atlas of Human Anatomy, Ciba-Geigy, 1995. Modified by the author)
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Pathology
Embryologically, the ectodermally lined stomodeum gives rise to the mucosa of the 
retromolar trigone, as well as to the mucosa of the lips, buccal mucosa, gingiva, floor of 
mouth and oral tongue. The mucosa of the RMT is lined by stratified squamous epithelium. 
It rests on a loose submucosa, which invests salivary glands, blood vessels, and nerves and 
is permeated by a rich lymphatic system (Figure 11).
The concept of “Step-wise” progression of human cancer has been clinically well 
recognized. The model of cancer evolution through the accumulation of mutations in both 
oncogenes and tumour-suppressor genes, and the stepwise selection of more malignant 
tumour-cell populations, has been widely adopted and generalized to all common forms of 
cancer, including oral cancer. Progressive epithelial changes in oral mucosa lead to 
development of hyperkeratosis, dysplasia, carcinoma in situ and, eventually, invasive 
carcinoma. This continuum of progression of epithelial transformation from a normal to a 
malignant cell may take years in some individuals. On the other hand, such sequential 
progressive cytologic changes are not obseiwed in all patients and indeed may be absent in 
many patients with invasive SCC (9).
By far, the most common malignancy arising in the RMT, as in the rest of the oral cavity, is 
squamous cell carcinoma (SCC) or epidermoid carcinoma, accounting for more than 90%. 
The remaining malignancies are primarily various types of carcinoma arising from minor 
salivary glands. The mucoepidermoid carcinoma of the minor salivary glands is more 
common in the RMT area compared with the adenoid cystic carcinoma, which is the most 
common malignancy of the minor salivary glands in general(lO). Additional rare tumors 
include lymphomas, melanomas, and a variety of sarcomas (osteosarcoma, fibrosarcoma, 
rhabdomyosarcoma etc).
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Figure 11 A. Retromolar trigone (RMT) mucosa, B. Hard palate mucosa, C. RMT mucosa 
from unfixed specimen, D. Buccal mucosa, E. Posterior tongue mucosa, F. Submandibular 
ganglion, G. Submandibular ganglion, H. Lingual nerve, I. Glandular tissue from RMT of 
unfixed cadaver, J. Ductal formation from RMT of unfixed cadaver, (photo taken from 
Stephen J. Goldie’s dissertation “The Effect of Surgical Incisions in the Region of the 
Retromolar Trigone” submitted to the University of Glasgow for partial fulfilment of the BSc 
(Honours) in Anatomy, 2001)
There are several ways of classifying SCC. Three gross morphologic growth patterns of 
SCC occur in the RMT area: exophytic, ulcerative, and infiltrative. The most common 
morphologic types of SCC of the RMT are ulcerative and infiltrative. Exophytic neoplasms 
are rare (8). Malignancies often display more than one of these manifestations.
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The exophytic form is least common. It tends to grow more superficially and metastasize 
later than the other types. This foim begins as an ar ea of thickened epithelium, which heaps 
up and can protrude 1 cm or more above the surrounding mucosa. Ulceration occurs early in 
its development. Exophytic carcinomas gradually become deeply infiltrative in more 
advanced cases.
The ulcerative type is the most common form of SCC. It begins as a round or oval ulcer with 
a grey, shaggy base that bleeds readily. Ulcerative types manifest a greater tendency for 
rapid infiltration and usually have a higher histologic grade than the exophytic type. The 
ulcer eventually may heap up and become exophytic or remain lower than surrounding 
mucosa.
Infiltrative malignancies initially appeal' as a firm mass or plaque covered by mucosa. This 
type of tumor extends deeply into underlying tissues, with minimal elevation above the 
surrounding mucosa. As the neoplasm progresses, ulceration and exophytic manifestations 
may be observed.
Classification by histologic features includes the following varieties (11):
Nonkeratinizing (transitional cell carcinoma, lymphoepithelioma).
Keratinizing.
Verrucous.
Spindle cell (pseudosarcoma, carcinosarcoma).
Adenoid squamous carcinoma (adenoacanthoma, pseudoglandular SCC.
Basaloid squamous caicinoma.
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Nonkeratinizing carcinomas tend to arise from respiratory-type mucosa whose cells are 
endodermally derived and may be well to poorly differentiated. These cancers are frequently 
associated with a lymphoid tissue stroma that is not an integral component o f the tumor. 
They occur frequently in the nasopharynx, pharynx, and larynx. Nonkeratinizing tumors 
show mainly submucosal spread and have "pushing" margins in 50% of cases.
Keratinizing SCC occurs in all areas of the upper aero digestive tract, with the greatest 
frequency in structures derived from the ectodermally lined stomadeum. In general, these 
carcinomas are ulcerative or fungating, show infrequent submucosal spread, have sharp 
infiltrating margins, and are well differentiated in 20% of cases. No differences exist with 
respect to lymph node métastasés or survival based on the feature of kératinisation.
Verrucous Carcinoma. The diagnosis of this interesting but uncommon variant of well- 
differentiated SCC requires concurrence between the pathologist and the clinician; that is, 
the diagnosis is clinicopathologic, and microscopic and clinical features must both be 
consistent with the diagnosis. The lesion is soft and circumscribed at first, but becomes 
indurated as it advances. This exophytic and warty growth occurs in areas of leukoplakia 
and consists of well-differentiated keratinized epithelium tlu own up into long, papillomatous 
folds. Histologically, the tumor consists of large, heavily keratinized fronds and downward, 
sharply projecting, circumscribed, bulbous rete pegs. The border is typically pushing rather 
than infiltrating. A dense inflammatory reaction occurs in the adjacent stroma. Cytologic 
features of malignancy (cellulai* atypia, mitoses) are lacking, and the basement membrane 
may appear intact.
Biopsies of the surface of the lesion are interpreted repeatedly as benign hyperkeratosis, 
delaying diagnosis and treatment. The differential diagnosis includes pseudoepitheliomatous 
hyperplasia, keratoacanthoma, and squamous cell papilloma. Verrucous carcinoma and well-
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differentiated SCC with a verrucoid appearance are considered separate entities. Deep 
biopsy at the base of the lesion is required to show the diagnostic features.
Verrucous "carcinoma" acts in a benign manner. Growth of the primary tumor is indolent, 
with erosion of underlying structures including bone, but little surface spread. The slow- 
pushing nature of growth gives few symptoms. This clinical pattern is interesting in view of 
tissue culture findings, which show that the typical growth pattern is rapid. Indeed, primary 
tumors can recur rapidly and repeatedly when incompletely excised.
The imiocent nature of verrucous cai'cinoma is further documented by the finding that, 
although regional lymph nodes can be enlarged, this is presumably caused by an 
inflammatory response to the heavy keratin deposits rather than by metastatic disease. 
Distant métastasés have never been reported.
Spindle Cell Carcinoma. In this rare variant of SCC, tumors tend to be polypoid or 
pedunculated masses. Symptoms result from the bulk and anatomic location of the tumors. 
They are friable, and patients may cough up parts of the tumor or have spotty bleeding. 
Histologically, spindle cell carcinoma consists of bizarre, spindle-shaped mesenchymal-like 
cells giving the impression of a highly anaplastic sarcoma with an overlying epidermoid 
carcinoma. The epidermoid component can be missed unless multiple sections are 
examined. Electron microscopy supports the classification of spindle cell carcinoma as a 
variant of SCC with no evidence of malignant degeneration of connective tissue. The 
carcinoma component is usually small and well differentiated. Tumor métastasés are present 
in 50% of cases, usually in the regional lymph nodes. The métastasés may demonstrate the 
epithelial or spindle pattern or both. The primary tumor tends to remain localized. Low- 
grade tumors can be treated by wide surgical excision, but poorly differentiated and invasive 
tumors should probably be treated with planned combined operation and radiotherapy.
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Adenoid Squamous Cell Carcinoma. This rare variant of SCC occurs primarily on the 
vermilion border of the lips and more rarely on the tongue and gingiva. The basic cell is of 
the keratinising squamous type. This lesion can be distinguished from salivaiy gland or 
metastatic tumor by acid mucopolysaccharide stains. The pathogenesis of this lesion is 
unknown. Adenoid SCCs of the lip are associated with a good prognosis and no regional 
métastasés or deaths. Within the oral cavity, these tumors behave similarly to SCC and have 
a greater tendency to lymph node metastasis.
Basaloid SCC (BSCC) is an aggressive, histologically distinctive variant of SCC that has a 
predilection for the upper aerodigestive tract (base of tongue, pyriform sinus, supraglottic 
larynx) although other sites including the anus, esophagus, and uterine cervix have also been 
reported. Since its first description in 1986, only about 90 patients have been reported in the 
English literature.
BSCC tends to occur in older populations, with male predominance. Its aggressive biologic 
behaviour is chaiacterized by a high incidence of cervical lymph node métastasés (64%), 
distant métastasés (44%), primarily to the lungs, liver, bones, brain, and skin, and death 
from disease: 38% mortality at 17 months median follow-up. The tumors are usually hard 
and centrally ulcerated, with submucosal infiltration.
Histopathologically, BSCC is distinctive. Microscopically, there is a dual population of 
cells, and the chai'acteristic growth patterns consist of lobules, nests, and cords of basaloid 
cells, comedonecrosis, nuclear palisading around the periphery of tumor lobules, small cyst­
like spaces surrounding material that resembles mucin, hyalinisation, prominent mitotic 
activity, and a surface component of dysplastic, in situ or frankly invasive SCC. Some 
reports note multifocal origin in overlying mucosa. Perineural invasion does not appear to be 
a prominent feature of the process.
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Keratin positivity is seen in the squamous cell component. Studies of oncogene expression 
in BSCC suggest that it is a distinct variant of SCC characterized by a poorly differentiated 
cell population.
In BSCC, basaloid and squamous cells ai*e intimately admixed, but the cellular composition 
is heterogeneous, and establishing the correct diagnosis on biopsy may be difficult or 
impossible. The two tumors that cause the most difficulty in differential diagnosis are 
adenoid cystic carcinoma (particularly the solid variant) and small cell undifferentiated 
(neuroendocrine) carcinoma. (11)
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Natural History 
Epidemiology
Oral cancer accounts for about 3-4% of all cancers and about 30% of all head and neck 
cancers. It is the 6^*’ most common cancer in men and the 12‘*' most common cancer in 
women, prevalence being highest in India. In the UK, oral cancer is estimated to account for 
1-4% of all malignancy, with 1900 new cases diagnosed annually (12). Although the most 
common intraoral site of carcinoma is the tongue, usually on the posterior lateral borders or 
ventral sui’faces, the floor of the mouth is also frequently affected. Together with the 
retromolar region, these areas comprise a horseshoe-shaped zone of increased cancer 
susceptibility, accounting for about 75-85% of all cases of intraoral cancer(13;14). 
According to Jovanovic et al retromolar area accounts for about 11.5% (79/690 patients) of 
SCC of the lip and oral eavity (15). Shumrick and Quenelle presented that nearly 50% of all 
carcinomas of the oral cavity and pharynx occur in the palatine arch (including the tonsil), 
the retromolar' trigone, and the adjacent buecal mucosa (16).
Due to the small size of the retromolar trigone, tumors arising here usually involve the 
adjacent anterior tonsillar pillar, tonsillar fossa, or soft palate. Distinguishing a single site of 
origin is often impossible; thus many physicians group retromolar trigone cancers with those 
of the palatine arch. The literature is sparse concerning malignancies specifically arising 
from the retromolai' trigone. In general, tumors with epicenters over the retromolar' trigone 
should be considered to arise from this site(8). Kowalski in his series reported 114 cases in 
32 y ear s( 17), Byers et al repoi’ted 110 cases in 13 years (18) and Huang et al repoi-ted 65 
cases in 24 years (19).
Cancer of the retromolar trigone is predominantly a disease of elderly men in the sixth and 
seventh decades of life. According to Byers et aTs retrospective analysis of the medical
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records of 110 patients seen and treated at The University of Texas M.D. Anderson Hospital 
and Tumor Institute with biopsy proven squamous carcinoma originating in the retromolar 
trigone, the average age of the 81 men and the 29 women (male to female ratio 2.8:1) was 
62, with a range of 38-85 years(18).
Aetiology
Tobacco and alcohol consumption are the most important risk factors for the RMT 
carcinogenesis, as they are for the rest of the oral cavity. There is good evidence that tobacco 
in all forms, including the tobacco in snuff and betel quid (a mixture of ingredients including 
betel leaf, aieca nut, slaked lime, and tobacco, which is wrapped in a betel leaf and chewed), 
is carcinogenic in the upper aerodigestive tract, which includes the mouth (20). There is 
fairly convincing evidence that alcohol is also a carcinogen and acts synergistically with 
tobacco (21). There is little convincing evidence that mouthwash use, poor oral hygiene, or 
oral infections of viral origin play an important role in the aetiology (22;23). Consuming 
fruit and vegetables may have a protective effect. There is a slight familial risk for oral 
cancer, which may be related to the similar exposures to tobacco and alcohol, which occur 
among family members (24). Table 1 summarises the risks factors of oral cancer.
Byers et al reported in their study that 97% smoked over one pack of cigarettes/day, and 
50% were admitted alcoholics (18).
Neoplasms in this area are part of a regional problem of upper aerodigestive tract carcinoma 
resulting from "field cancerization"(25). Field cancerization was first described in 1953 as 
histologically altered epithelium surrounding tumor samples taken from the upper 
aerodigestive tract. Since then, the term has been used to describe multiple patches of pre- 
malignant disease, a higher-than-expected prevalence of multiple local second primary 
tumors, and the presence of synclironous distant tumors within the upper aerodigestive tract.
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Bilateral cancer in the palatine arch region is not rai'e, and multiple primary tumors of the 
aerodigestive tract in general may be as high as 20%.
Normally, saliva provides a protective buffer between toxins and the lining of the mouth 
beeause it contains important enzymes that fight and neutralise harmful substances.
Reznick et al in their reseai’ch demonstrated that the chemicals in tobacco smoke combine 
with saliva with devastating effect. They destroy the protective components of saliva - 
leaving a corrosive mix that damages cells in the mouth and can eventually turn them 
cancerous. Thus, when exposed to cigarette smoke, salivary behavior is reversed and the 
saliva loses its antioxidant eapacity and becomes a potent prooxidant milieu (53).
Marshberg et al, in 1976, assumed the role of saliva as a medium for the carcinogens 
explaining the distribution of these lesions along the floor of the mouth, side of the tongue, 
retromolar trigone, and anterior pillar (and their paucity on the hard palate and huccal 
mucosa) (26).
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Table 1 Risk factors of oral cancer
Sm oking 2 - 4  times increased risk of developing cancer 
90% of patients with oral cancer use tobacco
M arijuana sm oking contains benzopyrene & benzantliracene higher concentration of 
cai’cinogens than that in cigarette smoke
Sm okeless tobacco  
(chew ing tobacco & 
sn u ff dipping)
contains tobacco-specific N-nitrosamines readily extracted into saliva 
(enhanced in alkaline environments)
A lcohol 2 - 2 0  times increased risk of developing cancer 75 - 80% of patients 
with oral cancer consume alcohol
T obacco  c& A lcohol non-drinking smokers: 2 - 4  times increased risk 
drinking smokers: 6 - 1 5  times increased risk alcohol: ?acts as a solvent 
for carcinogens by enhancing tissue penetration alters epithelial cell 
metabolism ereates nutritional deficiency states or suppresses 
immunity, causes hepatic cirrhosis and decreases ability to detoxify 
carcinogens
H abits o f  th ird  
w o rld
bidi, reverse smoking or betel nut chewing
M echanical traum a shai'p denture flanges, irregular or sharp teeth or restorations, food 
burn, spicy food, poor oral hygiene & other physical agents
Viruses papovavirus (including HPV), adenovirus, FISV & EBV, HIV
Im paired  immunity
O ther conditions Candida albicans, syphilis, lupus erythematosus, Plummer-Vinson 
syndrome, submucous fibrosis, sideropenic dysphagia, actinic keratosis 
& dyskeratosis congenita
Cancers of the retromolar trigone display biologie properties that more closely resemble 
SCC of the oropharynx than of the oral cavity. Thus cancer arising from this site most often 
appears with advanced disease. Approximately 30% to 60% of patients with such 
malignancies have clinical evidence of regional métastasés when first seen. Occult 
métastasés are present in 10% to 20% of patients (16). Métastasés occur most commonly to 
the upper deep jugular (subdigastric) lymph nodes, the submandibular and mid-deep jugular 
nodes. About 7% of patients develop contralateral métastasés. Finding distant métastasés at 
the initial evaluation is rare (16).
Patterns of spread
Due to the high association of alcohol and tobacco abuse and the genesis of SCC of the oral 
cavity, very often premalignant changes are visible or present before the development of
invasive carcinoma.
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Most epithelial premalignant changes present as white discoloration (leukoplakia). The risk 
of development of leukoplakia into invasive carcinoma has been estimated at approximately 
4% to 6%. Some patients may manifest premalignant changes by red discoloration 
(erythroplakia). The risk of development of invasive carcinoma in erythroplakia is as high as 
30%.
A varying degree of kératinisation usually is present on the surface of a primary tumor. The 
extent of kératinisation is a reflection of the degree of differentiation of the underlying 
malignant process.
Although the current staging system takes into account only the surface dimensions of the 
tumor, the third dimension (depth of invasion or thickness of the tumor) is important in 
terms of the risk of regional lymphatic dissemination and prognosis (27). Local extension by 
spread to adjacent structures may lead to invasion of the underlying soft tissues and muscles, 
bone, or neurovascular structures.
Local Spread
Local invasion of primary SCCs of the retromolar trigone may extend to the adjacent 
mucosa, manifesting a zone of invasion with progressive changes demonstrating carcinoma 
in situ and dysplasia in adjacent mucosa. The most common sites of extension are the soft 
palate, the tonsillar pillar, the lower gum, the buccal mucosa and the floor of mouth.
Extension of the tumor into the depth of the underlying tissues may cause invasion of the 
buccinator muscle, the superior constrictor of the pharynx, the buccal pad of fat, the 
masseter muscle, the temporalis muscle and the medial pterygoid muscle.
Further progression of local tumor spread may trigger invasion of neurovascular structures, 
causing vascular invasion and perineural invasion. The buccal, inferior alveolar and lingual 
nerves are all easily accessible to cancerous infiltration from the retromolar area. Although
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neurotropism is not a classic chai'acteristic of oral SCCs, some patients do manifest 
neurotropism with extension of tumor along the inferior alveolar nerve into the mandibular 
canal.
Bone invasion can take place by direct infiltration of the surface lesion into the underlying 
bone or through the dental sockets into the cancellous part of the mandible and mandibular 
canal. In edentulous patients, such direct spread may occur through "dental pores" on the 
edentulous alveolar ridge.(9;28-31)
Another phenomenon unique to the mucosa of the upper aerodigestive tract is field 
cancerization. Patients with significant exposure to tobacco and alcohol often demonstrate 
altered mucosa that is highly susceptible to the development of multiple primaiy cancers. In 
such patients, varying degrees of epithelial changes may be present, reflecting changes at 
different stages of development of invasive cancers (32). This process eventually leads to the 
development of multiple synchronous or metachronous primary carcinomas in the mucosa at 
risk. The occurrence of multifocal changes, however, is seen in the pharynx more often than 
in the oral cavity.
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Regional Spread
The risk of dissemination to regional lymphatics is related to the size of the primaiy tumor, 
the depth of invasion, and the histological grade. The factors that increase the risk of 
lymphatic dissemination from a primary cancer of the RMT are listed in Table 2.
Table 2 Factors that influence the risk of lymph node metastasis
• Size
• T stage
• Histomorphologic features
- Endophytic vs. exophytic 
Tumor thickness
Differentiation (well differentiated vs. poorly differentiated)
Once lymphatic invasion occurs, malignant cells travel through the lymphatics to the first- 
echelon lymph node (sentinel lymph node), usually situated in the upper deep jugular lymph 
nodes. The submandibular and mid-deep jugular nodes become involved secondarily. Based 
on the idea that cancer cells spread in an orderly way from the primary tumor to the sentinel 
lymph node(s), then to other nearby lymph nodes, sentinel node biopsy is emerging as a 
successful means of identifying subclinical lymph node disease in mucosal head and neck 
cancer (54).
Approximately 50% to 60% of patients with retromolar trigone cancer have clinical 
evidence of regional métastasés when first seen. Occult métastasés are present in 10% to 
20% of patients. About 7% of patients develop contralateral métastasés.(16)
Distant Spread
Distant métastasés from primary SCCs of the RMT at the time of initial diagnosis are rare. 
Dissemination to distant sites without local progression or regional spread usually does not
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occur. On the other hand, patients with advanced-stage lymph node metastasis (N2 or N3 
disease) or those with recurrent disease are at a significant risk of dissemination to distant 
sites. Distant métastasés usually occur in the lung, bones, brain, and other sites.
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Clinical Presentation and Diagnosis
Most patients with cancer of the retromolar trigone complain primai'ily of pain. A persistent 
sore in the mouth, odynophagia, and a burning sensation when drinking citrus juices are 
other common symptoms. Referred otalgia may be encountered as the tumor extends 
medially into the tonsil. Trismus, a mass in the neck, or hearing loss suggests advanced 
disease. Trismus usually indicates that the neoplasm has infiltrated deeply into the pterygoid 
musculature. Hearing loss is the result of tumor extension toward the nasophaiynx and 
involving the region of the eustachian tube (8).
The mean duration of symptoms is approximately 5.1 months according to Barbosa (2). 
Because of its relatively limited surface area, lesions arising in the retromolai' trigone 
frequently invade adjacent areas. The most common sites of extension are the soft palate, the 
tonsillar pillar, the buccal mucosa, the lower gum and the mandible(17-19). The overall 
incidence of pathologically proven cancer invading bone is 12-15% (18).
Evaluation of patients with carcinoma of the retromolar trigone involves thorough inspection 
and palpation as with other sites in the oral cavity. Before instituting therapy, examination 
under anesthesia and biopsy of all tumors is necessary. While superficial tumor spread 
seldom evades diagnosis, deep extension can be difficult to diagnose accurately. When 
malignancy of the RMT extends deeply, patients may experience anesthesia of the 
mandibular division of the trigeminal nerve or trismus, however the clinical exam does not 
always accurately reflect the extent of disease. While the presence of trismus suggests 
pterygoid invasion until proven otherwise, trismus may not necessarily represent direct 
tumor extension and may result from inflammation of the adjacent pterygoid musculature. 
Similarly, invasion of the mandible is often under diagnosed on clinical exam. Periosteal and 
cortical bone invasion is often difficult to assess clinically. Imaging studies such as 
panoramic radiographs and Computed Tomography (CT) scamiing can be helpful if cortical
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erosion has occurred however these methods remain imperfect. Lane et al. reviewed the use 
of CT to assess mandibulai' invasion and found that bone invasion was not detected in 27% 
of patients with preoperative scans and that the sensitivity of CT for mandibular invasion 
was only 50% (55). The failure to accurately diagnose bone invasion preoperatively can 
have a significant impact on treatment and prognosis upgrading a stage T2 mucosal lesion to 
a stage T4 lesion. In an effort to improve preoperative diagnostic accuracy, Crecco et al. 
evaluated 22 patients with SCC of the RMT using 1.5T superconductive Magnetic 
Resonance Imaging (MRI) to evaluate medullary and cortical bone invasion (56). In this 
study, preoperative MRI staging correlated with pathological data in 19 of 22 patients 
resulting in an overall accuracy of 86%. The MRI did not significantly aid in defining 
mandibular invasion however it provided an excellent method to assess the adjacent soft 
tissue, including perineural spread and pterygoid involvement. Because the accurate 
evaluation of tumor extension is critical to treatment planning and prognosis, Genden et al 
recommend a PANORAMIC radiograph and CT scan for all patients presenting with a 
tumor of the RMT (57). In those patients that demonstrate trismus, extensive soft tissue 
involvement, or sensory disturbance, including pain, they include an MRI to assess extent of 
soft tissue invasion.
Neither fluorodeoxy glucose positron emission tomography (FDG-PET) nor ultrasound has 
a specific role in the first line investigation of primary head and neck tumours, though they 
may occasionally be of value in difficult diagnosis.
Malignancies arising from the retromolar trigone frequently spread onto the soft palate, 
anterior tonsillar pillar, and tonsillar fossa. As the tumor progresses, inferior extension 
occurs into the tongue base, as well as superior extension toward the maxillary tuberosity. 
The involvement of the tongue base by neoplasm and the high incidence of multiple primary 
tumors require endoscopie evaluation, including direct laryngoscopy, oesophagoscopy, and
38
bronchoscopy, in order to rule out the possibility of synchronous multiple primary 
carcinomas in the upper aerodigestive tract.
In addition to the evaluation of the primary lesion and assignment of a clinical stage and 
confirmation of tissue diagnosis, pre-treatment dental evaluation is vitally important in 
treatment planning. Patients with loose teeth in the proximity of the tumor should not have 
any dental extractions prior to surgical intervention. Premature extraction of teeth opens up 
new tissue spaces and raises the risk of further local progression of disease by exposing 
tooth sockets and opening up the mandibular canal for potential tumor implantation and 
progression.
The lymph node status of the neck is the most important prognostic factor for patients with 
head and neck squamous cell carcinoma (HNSCC). There are several important prognostic 
features like the presence but also number of nodal métastasés, level in the neck, size of the 
nodes, and presence of extranodal spread. If métastasés in the neck are diagnosed, the neck 
should be treated. Because both sensitivity and specificity of palpation are in the range of 
60% to 70%, a neck without palpable lymph nodes (NO) is still at risk of harbouring occult 
métastasés. Therefore, much effort has been devoted to increase the accuracy of assessment 
of the NO neck. Both CT and MRI of the neck have been found to be superior to palpation in 
detecting cervical métastasés, but still have a relatively low accuracy for the NO neck. The 
sensitivity of UltraSound-guided-fme-needle aspiration cytotology (US-guided FNAC) in 
the detection of neck métastasés in the NO neck ranges from 42% by Takes, and 50% by 
Righi (58), to 73% by van den Brekel et al (59). The specificity is almost 100%, this is 
because false-positive cytologic results of lymph nodes are very rare, A sensitivity of 73% is 
significantly better than CT or MRI. A sensitivity of 42% or 50% is inferior to the 60% for 
CT. The cause of this variation is largely unknown. Where the nodal staging on CT or MRI 
is equivocal, US-guided FNAC and/or FDG-PET increase the accuracy of nodal staging.
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An invasive technique for staging the clinically NO neck is sentinel node biopsy. The 
concept of the sentinel node approach is based on the knowledge that nodal métastasés 
progress in an orderly manner with the first site of métastasés occurring in the sentinel node. 
Initial reports on sentinel node biopsy in oral cancer have shown promising results (60). The 
sentinel node detection technique involves injecting around the primary tumour site with Tc- 
99m-labelled colloid. The localization of the sentinel node is then performed by planar 
scintigraphy and the use of a hand-held gamma camera.
staging
Table 3 & Table 4 lists the criteria for clinical classification of histologically confirmed 
squamous cell carcinoma of the oral cavity, according to the 1996 American Joint 
Committee Manual for Staging Cancer 5^ ’^ edition (3).
Table 3 TNM staging of SCC of the upper aerodigestive tract.
T X Tumour size camrot be assessed, e.g. unknown primary
is Carcinoma in-situ
1 Tumour size <2cm
2 Tumour size 2-4cm
3 Tumour size >4cm
4 Tumour invading deeper structures
N X Regional lymph node status cannot be assessed
0 No nodal métastasés
1 Metastasis in single ipsilateral node, <3 cm in greatest dimension
2a Metastasis in single ipsilateral node >3cm but <6cm in greatest 
dimension
2b Métastasés in multiple ipsilateral nodes, none >6cm
2c Métastasés in bilateral or contralateral nodes, none >6cm
3 Metastasis in a node >6cm in maximum dimension
M X Distant métastasés cannot be assessed
0 No distant métastasés
1 Distant métastasés present
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Table 4 Stage Grouping
Stage I TINOMO
Stage II T2N0M0
Stage III T3N0M0, T1/2/3N1M0
Stage IV T4N0M0, T4N1M0, anyTN2/3M0, anyT anyN M l
In the sixth edition of the American Joint Committee Manual for Staging Cancer (2002), a 
uniform descriptor for size for all head and neck sites was introduced (61). In addition, for 
T4 tumors (lai-ger than 4 cm), subcategories a and b were introduced based on involvement 
of vital structures and thus their suitability for surgical resection. T4a implies locally 
advanced but resectable tumor, while T4b implies tumor that is not technically resectable but 
is suitable for nonsurgical options such as chemoradiotherapy.
For oral cavity:
T4a means that tumor invades adjacent structures (eg, through cortical bone, into deep 
extrinsic muscle of the tongue genioglossus, hyoglossus, palatoglossus, and styloglossus, 
maxillary sinus, skin of face). Superficial erosion alone of bone/tooth socket by gingival 
primary is not sufficient to classify as T4
T4b means that tumor invades masticator space, pterygoid plates, or skull base and/or 
encases internal carotid artery
There have been no modifications to the N and M staging system for oral cavity.
Thus, regarding Stage Grouping for oral cavity. Stage IV has been subdivided into:
Stage IVA T4a NO MO
T 4aN l MO 
T1 N2 MO 
T2 N2 MO 
T3 N2 MO 
T4aN2 MO
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Stage IVB T4b Any N MO 
Any T N3 MO
Stage IVC Any T Any N M l
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Management
Factors affecting choice of treatment
The factors that influence the choice of initial treatment are those related to the 
characteristics of the primary tumour (tumour factors), those related to the patient (patient 
factors), and those related to the treatment delivery team (physician factors). In the selection 
of optimal therapy, therefore, these thi'ee sets of factors for treatment planning require to be 
considered. Clearly, the goals of treatment are a) curing the cancer, b) preserving or 
restoring form and function, c) minimizing the sequelae of treatment, d) delivering the 
optimal treatment in a cost-effective and expeditious manner, and e) preventing second 
primary tumours(9). To achieve these goals, the currently available therapeutic modalities 
include surgery, radiation therapy, chemotherapy, and combinations of these for the control 
of the presenting tumour and for primary and secondary prevention strategies, with lifestyle 
changes for reducing the risk of multiple primary tumours.
Tumour Factors
The tumour factors that influence the choice of initial treatment are related to size (T stage), 
invasion of adjacent areas, proximity to bone (mandible or maxilla), status of cervical lymph 
nodes, and pathology of the primary tumour (histological type, grade, and depth of 
invasion). In addition to this, any previous treatment rendered to the lesion will influence the 
choice of therapy.
The size of the primary tumour clearly has a heavy impact on the decision regarding the 
choice of initial therapy. Small and superficial primaiy tumours are easily accessible for a 
relatively simple surgical excision through the open mouth. On the other hand, larger 
tumours that invade adjacent areas will require more extensive surgical approaches for 
exposure and excision. In addition to tliis, with increasing size and the depth of infiltration
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of the primary lesion, the risk of regional lymph node metastasis increases, bringing into 
consideration the need for elective treatment of the clinically negative neck at risk of having 
micrometastasis.
The histology of the primary tumour is an important parameter that has an impact on 
selection of initial treatment. Though most SCCs are radioresponsive, those with excessive 
keratin deposits and verrucous carcinomas are relatively less radioresponsive. The 
histological grade of the lesion generally reflects the aggressiveness of the tumour. Both 
poorly differentiated and undifferentiated carcinomas are predictably more aggressive in 
comparison to moderately well- and well-differentiated carcinomas. However, the most 
crucial primary tumour histological feature having an impact on selection of initial therapy 
and eventual prognosis is its depth of infiltration. Thin and superficially invasive lesions that 
have a lower risk of regional lymph node metastasis, are highly curable, and offer an 
excellent prognosis. On the other hand, thicker lesions that deeply infiltrate the underlying 
soft tissues have a significantly increased incidence of regional lymph node metastasis, with 
its adverse impact on prognosis. Though it would be ideal to know the thickness of the 
lesion before surgical intervention, in most instances, securing that information prior to 
surgical excision of the primary tumour is clinically impractical. Therefore, thickness of the 
lesion as appreciated by palpation, generally is reasonably effective in distinguishing deeply 
invasive lesions from superficial lesions, in estimating the extent of soft-tissue or bone 
resection for the primary tumour, and in deciding on the need for elective dissection of 
regional lymph nodes at risk in the clinically negative neck.
Patients with advanced stage of disease (i.e., those presenting with spread to regional 
cervical lymph nodes or with large primary tumours, such as T3 and T4) are candidates for 
consideration of combined modality treatment. Currently, surgical resection followed by 
postoperative radiation therapy is considered standard treatment for most patients with stage 
III and stage IV SCCs (9).
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Patient Factors
Several factors related to patient characteristics are important in the selection of initial 
treatment. These are patient's age, general medical condition, occupation, tolerance to 
treatment, acceptance and compliance with the recommended therapy, lifestyle (smoking 
and drinking), and socioeconomic considerations. Older age generally is not considered to 
he a contraindication for implementation of adequate initial surgical treatment. However, 
with advancing age, intercurrent disease, and debility secondary to associated 
cardiopulmonary conditions, the implementation of extensive surgical intervention poses 
increased risk. The ability of the patient to tolerate an optimal therapeutic program is 
similarly an important facet that can influence the choice of initial therapy. Patient's 
occupation, acceptance, and compliance for the proposed treatment program are similarly 
important considerations in plamiing optimal therapy for the tumor. Patient's lifestyle, 
particularly with reference to the habit of smoking and drinking, has a heavy impact on the 
selection and tolerance of the treatment offered. Unwillingness on the part of the patient to 
give up the habits of smoking and drinking further complicates the administration of 
adequate treatment and increases the risk of multiple primary tumors. Finally, 
socioeconomic considerations have started playing an increasing role in the selection and 
implementation of initial therapy in a cost-effective mamier. Allocation of resources 
required to deliver therapy have to be judged on the basis of outeomes analysis of a 
particular treatment program. Previous treatment for other lesions in the same area also will 
influence the decision regarding selection of treatment. For example, radiation therapy 
previously delivered to the same ai*ea for a different lesion may not be available to treat a 
second tumour in the same area.
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Physician Factors
Several physician- and provider-related factors also are important in the selection of initial 
therapy. These factors are related to the technical and professional skills in surgery, radiation 
therapy, chemotherapy, rehabilitation services, dental, and prosthetic services and 
psychosocial support services. Management of oral cancer is a multidisciplinary team effort, 
and teclinical capabilities and support services from various disciplines are essential for a 
successful outcome. A comprehensive head and neck disease management team would 
consist of the head and neck surgeon combined with other suigical specialties microsurgery, 
neurosurgery, vascular surgery, plastic and reconstructive surgery, and dental surgery— and 
prostheses. Similar expertise in radiation oncology (including brachytherapy) is essential for 
integration of combined treatment programs of external, interstitial, and altered fractionation 
as well as radiation therapy and chemotherapy. A well-organized team of medical 
oncologists expert in administration of chemotherapeutic drugs and the management of 
chemotherapy-related complications is essential in the management of patients with 
advanced disease and recurrent tumours. Professions allied to medicine such as speech 
therapy, dieticians, physiotherapists, psychologists, nurse counsellors, social workers, dental 
hygienists, prosthodontists, maxillofacial laboratory are vitally important for long-term 
restoration of the quality of life after treatment of oral cancer.
Selection of initial treatment
Since the natural history of tumors in this area is unclear, the optimal treatment remains ill 
defined. Early reports supported surgical therapy over external beam irradiation (2), 
however surgical treatment of extensive lesions, particularly those that involve the soft 
palate and pharynx, can result in significant functional deficits in speech and swallowing. 
Byers et al reviewed the M.D. Anderson experience in 1984 (18). They reviewed 110 cases 
of RMT carcinoma, 70 lesions were staged T1—T2, and 77 patients had NO necks at the
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time of diagnosis. The authors reported a recurrence rate of 16% in patients treated with 
radiation therapy alone and 18% in patients treated with postoperative radiation, and an 
overall 5-year survival rate of 20%. In this report, Byers et al. concluded that radiation 
therapy or surgery alone resulted in equivalent disease free survival regardless of the T or N 
stage (18).
Three years later, Lo et al again reviewed the M.D. Anderson experience of irradiation of 
anterior faucial pilar-RMT tumors and reported an overall survival of 83%(50). The failure 
rate was 29% for T1 lesions, 30% for T2, 24% for T3, and 40% for T4 lesions, however 
after salvage, the ultimate failure rates were 0% for T1 lesions, 6% for T2, 8% for T3, and 
20% for T4 lesions. Complications in this series were significant with 30% of patients 
developing bone exposure.
In 1993, Kowalski et al reported their experience with the extended ‘commando’ operation 
for the treatment of RMT carcinoma (17). In this series of 114 patients, 66 patients were 
treated with postoperative radiation (median 50 Gy) and achieved a 5-year actuarial survival 
rate of 80% for T1 tumors, 57.8% for T2, 46.5% for T3, and 65.2% in those with T4 tumors. 
In this study, 27.2% of patients experienced local recurrence; hence the authors recommend 
postoperative radiotherapy as an adjunct modality in patients with advanced primary tumors 
and those with metastatic disease at presentation.
More recent literature supports that surgery combined with postoperative or preoperative 
radiation offers better loeoregional control and disease-free survival than radiation or 
surgery alone (19). Huang et al reported the experience at Washington University with long­
term radiation therapy (19). This group reviewed 65 patients who were treated with 
preoperative radiotherapy (15%), postoperative radiotherapy (60%), or radiation therapy 
alone (23%) and found a 5-year disease free survival rate of 90% with preoperative 
radiation, 63% with postoperative radiation, and 31% with radiation alone. On multivariate
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analysis, Huang et al concluded that N stage had a significant impact on disease free survival 
and rates of distant metastasis. In contradistinction to these findings, the Radiation Therapy 
Oncology Group demonstrated no significant difference in 4-year overall survival and 
loeoregional control in a randomized study of different treatment modalities (62). In this 
series of 70 patients randomized to preoperative radiation (30%), postoperative radiation 
(36%), and definitive radiation (33%), loeoregional control was 43, 52, and 38%, 
respectively.
Similar to previously published reports, margin status is the most significant predictor of 
loeoregional control (63-65) and nodal status has the most significant impact on distant 
metastasis, and hence disease-free survival (66). Consistent with these observations, the 
addition of radiation therapy, either preoperatively or postoperatively, confers a significant 
survival advantage for patients with carcinoma of the RMT.
The treatment decisions in the management of RMT depend upon the stage at presentation, 
the patient’s general medical condition and symptomatology and the proximity of the lesion 
to the mandible. Small stage I tumours can be managed equally well by sui'gery only or 
radiotherapy only. Stage I tumours managed by surgery are reconstructed with local flaps or 
split-thickness skin grafts. Larger stage II neoplasms frequently require resection of portions 
of the soft palate, which increases morbidity from the standpoint of speech and deglutition. 
In general, radiotherapy only does not cure the deeply infiltrating cancers that cause trismus. 
These lesions should be treated surgically.
Stage III and IV cancer of the retromolar trigone should be managed by combined surgery 
and radiotherapy.
Accurate and individualized estimation of survival in patients with HNSCC would 
undoubtedly lead to an improvement in therapeutic and care strategies, minimizing risks of 
under-treatment and over-treatment. Baatenburg et al developed a statistical model in which
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the prognostic value of age, gender, site of the primary tumor, T-, N~, and M-stage, 
histological data, molecular biology markers, prior malignancies and other prognostic 
factors, are integrated to predict survival probabilities (67). All these data of a newly 
diagnosed patient with HNSCC are entered in a dedicated computer software program, 
called OncologlQ®, which immediately calculates and displays the survival curve for that 
individual onscreen. This would allow for a more precise and individual prediction of 
outcome in HNSCC patients. Therefore, this model may help in clinical decision making 
and appropriate counseling of patients with HNSCC.
Surgical approaches
A  variety of surgical approaches (oral approach, mandibulotomy approach, lower cheek flap 
approach, visor flap approach, upper cheek flap approach) as shown in Figure 12, are 
available for access in the oral cavity.
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Figure 12 Surgical approaches to carcinoma of the oral cavity. (A) Oral approach. (B) 
Mandibulotomy approach. (C) Lower cheek flap approach. (D) Visor flap approach. (E) Upper 
cheek flap approach. (Reproduced from Shah JP. Head and neck surgery, 2nd ed. London: 
Mosby-Wolfe, 1996.)
Small superficial primary lesions of the retromolar trigone can be excised via an oral 
approach. Most of the lesions of that area require a mandibulotomy approach (Figure 13).
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Figure 13 Mandibulotomy (Reproduced from JP Shah. Head and neck surgery, 2nd ed. 
London; Mosby-Wolfe, 1996.)
A typical resection (including 1 cm margins around the tumour) includes the retromolar 
trigone, the tonsillar fossa, and a portion of the floor of the mouth, soft palate, and buccal 
mucosa. The majority of the pterygoid musculature should be included with the specimen. 
Tooth extraction at the anterior bone resection margin permits saw cuts through tooth 
sockets, which prevents injury to adjacent tooth roots. Preserving as much of the mandible 
body as is oncologically prudent will decrease the resulting functional and cosmetic 
deformity.
Management of the mandible
Primary carcinomas of the oral cavity extend along the surface mucosa and the submucosal 
soft tissues and approach the attached lingual, buccal, or labial gingival. From this point 
onward, the tumour does not extend directly through intact periosteum and cortical bone 
toward the cancellous part because the periosteum acts as a significant protective barrier. 
Instead, the tumour advances along the attached gingiva toward the alveolus. In patients
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with teeth, the tumour extends through the periodontal ligament into the cancellous part of 
the bone. In edentulous patients, the tumour extends up to the alveolar process and then 
infiltrates the bone defects in the alveolar process and thence extends to the cancellous part 
of the mandible (28;30;31). Therefore, in patients with tumours close to the alveolar crest of 
the mandible (or even those demonstrating early invasion of the mandible), marginal 
mandibulectomy (Figui'e 14) is feasible, as the lower cortex of the mandible inferior to the 
roots of the teeth remains uninvolved and can be spared.
Figure 14 Marginal mandibulectomy. (Reproduced with permission of the author and 
publisher from JP Shah. Head and neck surgery, 2nd ed. London: Mosby-Woife, 1996.)
In edentulous patients, however, the feasibility of marginal mandibulectomy depends on the 
vertical height of the mandible. With aging, the alveolar process recedes, and the mandibular 
canal gets closer and closer to the alveolar surface. Resorption of the alveolar process 
eventually leads to a "pipestem mandible" in very elderly patients. The ability to perform a 
satisfactory marginal mandibulectomy in such patients is nearly impossible, owing to the 
risk of iatrogenic fracture intraoperatively or spontaneous fracture in the postoperative 
period due to weakening and avascularity of the residual mandible.
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When tumour extension involves the cancellous part of the mandible, a segmental 
mandibulectomy (Figure 15) must be performed. Segmental mandibulectomy also may be 
required in patients who have massive primary tumours close to the mandible and significant 
soft-tissue disease adherent to or surrounding the mandible.
W
Figure 15 Segmental mandibulectomy. (Reproduced from JP Shah. Head and neck surgery, 
2nd ed. London: Mosby-Wolfe, 1996.)
However, segmental mandibulectomy never should be considered simply to gain access to 
the primary oral cavity tumour that is not in the vicinity of the mandible.
The in-continuity tumor excision with mandibulectomy and neck dissection is called 
“commando operation” (“Com.m.a.n.d.o.” stands for “COMbined Mandibulectomy And 
Neck Dissection Operation”). The concept of the commando operation needs to be 
redefined, as no lymphatic channels pass tlirough the mandible, therefore not warranting the 
need for an in continuity composite resection of the uninvolved mandible.
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Management of the neck
Treatment of the regional lymph nodes is an integral component of the management of 
patients with squamous cell carcinoma (SCC) of the head and neck region. For several 
decades since the begiiming of this century, sui'gical treatment of cervical métastasés 
consisted of radical neck dissection (RND) as described by Crile (33) in 1906 and 
popularised by Martin et al. (34) during the 1950s. During the last 20 years, significant 
changes have occurred in the treatment of the neck. As a result, today RND is not the only 
operation used for surgical treatment of the neck, and surgery is not the only treatment for 
every patient with cervical lymph node métastasés. A recent review of neck dissection 
terminology was performed by Robbins (35) in which he outlined the consensus report on 
neck dissection terminology by the American Academy of Otolaryngology -  Head and Neck 
Surgery. These more accurate and descriptive terms are used thioughout this Thesis and the 
terminology is summarised in Table 5, Figure 16 and Table 6.
Table 5 Neck dissection levels
Level of Neck Dissection Anatomical Description
I Submandibular triangle and Submental triangle. 
Anatomical borders: lower border of the mandible 
and the bellies of the digastric muscle; hyoid bone 
and the midline.
II Upper jugular nodes.
Anatomical borders: skull base to bifurcation of 
common carotid artery at the level of the hyoid 
bone; lateral border of sternohyoid muscle to 
posterior border of sternocleidomastoid.
III Middle jugular:
Anatomical borders: inferior border of level II to 
the omohyoid muscle at the level of the cricothyroid 
membrane; lateral border of sternohyoid muscle to 
posterior border of sternocleidomastoid.
IV Lower jugular:
Anatomical borders: from the inferior border of 
level III to the clavicle; lateral border of sternohyoid 
muscle to posterior border of sternocleidomastoid.
V Posterior triangle
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Figure 16 Levels of lymph nodes
Table 6 Neck Dissection Terminology
Terminology Description
RND Radical neck dissection excising levels 
I-V, including the SAN, IJV and SCM
MRND-I Excising levels I-V, including the IJV 
and SCM
MRND-II Excising levels I-V, including the IJV
MRND-III Excising levels I-V, all three non­
lymphatic structures spai'cd
Selective Neck Dissection Excision of up to four levels of cervical 
nodes, usually sparing some or all non­
lymphatic structures
SOHND Supraomohyoid neck dissection, 
excising levels I-III, sparing all non­
lymphatic structures
Anterolateral Neck Dissection Excision of levels I-IV
Posterolateral Neck Dissection Excision of levels II-V
Extended Neck Dissection Excision of levels I-V with further 
dissection continued to deeper 
structures (e.g. pharyngo-laryngeal 
nodes, tracheo-oesophageal nodes, 
parotid nodes, etc)
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The consensus report on neck dissection terminology states that a RND is as described by 
Crile, excising the lymph nodes in levels I-V and including the spinal accessory nerve 
(SAN), sternocleidomastoid muscle (SCM) and internal jugular vein (IJV). Those 
procedures in which all five levels of nodes are excised but one or more of the tliree non­
lymphatic structures are spared are called modified radical neck dissections (MRND). A 
neck dissection, which leaves one or more of the nodal tissue from levels I-V within the 
neck, is called a selective neck dissection, and usually spares the IJV, SAN and SCM. 
Selective neck dissections may be described according to the levels that ar e removed or may 
be termed descriptively.
More than ever before, appropriate management of the cervical lymph nodes requires a good 
understanding of the incidence, patterns, and prognostic implications of lymph node 
métastasés and of the role of combined surgery, radiation therapy, and chemotherapy in the 
treatment of the neck in cancer patients.
Incidence o f cervical métastasés
The propensity of SCCs of the upper aerodigestive tract to metastasise to the cervical lymph 
nodes varies depending on the site of origin of the lesions and on size or tumour (T) stage. 
Lindberg's (36) classic incidence figures (based on the presence of palpable 
lymphadenopathy in more than 2,000 patients with SCC of the head and neck) have been 
refined by the studies of Byers et al. (37) and Shah (38), in which a large number of neck 
dissection specimens were evaluated (Table 7 & Table 8). From these observations, it is 
clear that carcinomas of the retromolar trigone have a relatively high propensity to 
metastasise to the lymph nodes. The rate of occurrence of lymph node métastasés in patients 
with small (T1 and T2) and large (T3 and T4) tumours is between 35% and 65%.
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Table 7 Incidence of lymph node métastasés (based on physical examination)
Percentage of necks with
nodal métastasés
Site of primaiy tumour T1 T2 T3 T4
Oral cavity
Oral tongue 0.14 0.30 47.50 76.50
Floor of mouth 0.11 0.29 43.50 53.50
Retromolar trigone 11.50 37.50 0.54 67.50
Oropharynx
Tonsil 70.50 67.50 0.70 89.50
Base of tongue 0.70 0.71 74.50 84.50
Pharyngeal walls 0.25 0.30 0.67 0.76
Larynx
Glottic 0.39 41.50 64.50 0.59
Supraglottic 0.63 69.50 0.79 73.50
Flypopharynx 92.50 84.50 88.50 0.83
Table 8 Incidence of histopathologic lymph node m étastasés
Site of primary tumor TL2 T3-4
Oral cavity
Oral tongue 18.6 31.6
Floor of mouth 18.6 26.3Lower gum 11.5 13.3
Buccal mucosa — —
Retromolar trigone 36.4 33.3
Oropharynx
Tonsil -—
Base of tongue — 50.0
Pharyngeal walls 20.0 62.5
Larynx
Glottic 21.4 14.0Supraglottic 30.8 25.0
Hypopharynx
Pyriform sinus 66.7 55.2
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Anatomie and radiographie studies of the lymphatics of the head and neck have 
demonstrated that the lymphatic drainage of the different aieas of the upper aerodigestive 
tract occurs along predictable pathways (39). Furthermore, clinical studies (38) have 
demonstrated that tumours from these areas metastasise to the lymph nodes following the 
same pathways, at least as long as the neck has not been treated previously with surgery or 
radiation therapy (Table 9). A now commonly accepted concept is that the lymph node 
groups that harbour métastasés most often in patients with carcinomas of the oral cavity are 
the submental (la), submandibular (lb), upper jugular (II), and midjugular nodes (111). From 
these, the submandibular (lb) and upper jugular (II) lymph nodes are the most commonly 
involved in the retromolar trigone cancers.
These patterns of distribution have been shown convincingly to occur both in patients who 
are staged NO clinically and are found to have occult métastasés and in patients with 
palpable, histologically proved lymph node métastasés (38).
Controversies exist amongst clinicians as to which type of neck dissection is most 
appropriate for varying disease patterns. The more radical the dissection, the greater the 
likelihood of significant morbidity arising from the procedure. Conversely, the less nodal 
tissue removed, the more likely it is to leave nodal tissue infiltrated with malignancy. Also, 
sparing of non-no dal structures is technically more demanding than a traditional RND, and 
therefore increases the time spent by the patient under general anaesthesia.
Regarding the retromolar trigone cancer treatment protocol at Camiiesburn Hospital, patients 
with a clinically positive neck underwent a therapeutic neck dissection, if possible a MRND 
type 111. Most of the patients with a clinically negative neck underwent elective neck 
dissection, for better access to the primary tumour, reconstruction requirements or cases
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Table 9 P attern  of nodal métastasés
Primary site Percentage of nodal involvement
lA IB 11 III IV V
Oral tongue 3.3" 22.8 59.7 10.7 2.6 7.0
9.0" 18.0 73.0 18.0 —- —
C 14.0 19.0 16.0 3.0 —
Floor of mouth 4.3" 43.1 37.1 9.5 4.3 1.7
7.0" 64.0 43.0 — — —
c 16.0 12.0 7.0 2.0 —
Buccal mucosa a •—^ •— — — —
__b — ■— —
c 44.0 11.0 — — —
Lower gum a
__ b 60.0 40.0 — — —
c 27.0 21.0 6.0 4.0 2.0
Retromolar trigone 0.6" 17.1 61.8 16.4 3.3 0.6
__ b 25.0 63.0 12.5 — —
c 19.0 12.0 6.0 6.0 0.0
Supraglottic larynx 0.5" 1.0 47.6 34.0 10.7 6.3
b — 48.0 38.0 5.0 —
c 6.0 18.0 18.0 9.0 1.5
Glottic larynx a
b — 55.0 27.0 — —
c — 21.0 29.0 7.0 7.0
Based on clinical examination (3).
^Based on examination of selective neck dissections (4). 
%ased on examination of radical neck dissections (63-65).
deemed at high risk for developing ceiwical metastasis. Sparing of as many non-nodal 
structures as possible for functional preservation remains one of the principles of the
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Caiiniesburn management philosophy, especially in the management of the clinically NO 
neck.
Reconstruction
Reconstruction of the oral cavity is essential in order to restore function and as much as 
possible make it aesthetically pleasing.
Following the concept of the reconstructive ladder, healing by secondary intention, primary 
closure, skin grafts (full or split thickness) and flaps (random, axial, myocutaneous, 
fasciocutaneous and free flaps) are the available reconstructive options. Primary closure, 
skin grafting and random flaps (buccal, tongue flaps) are feasible only for very small and 
superficial tumors.
Larger defects of the retromolar trigone require most often the use of a free flap or a 
pedicled flap for closure. Pectoralis major myocutaneous flap was and, in some places 
without microsurgery facilities, still is the workhorse for reconstruction.
Radial forearm and anterolateral thigh fasciocutaneous free flaps are the most commonly 
used free flaps for reconstruction of the retromolar trigone area. Other less often used free 
flaps are the scapular, the lateral arm and the latissimus dorsi.
When the mandible needs to be reconstructed the most common osteocutaneous donor sites 
are the fibula, the ilium, the scapula and the radius.
Radiotherapy
The goal of treatment for most cancers is to provide the best chance of cure. For early 
lesions of the oral cavity, either radiotherapy (RT) or surgery produces similar rates of local 
control, regional control, control above the clavicles, and 5-year cause-specific survival.
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However, the treatments may have substantially different morbidities and may result in 
differences in quality of life. Approximately 90% of head and neck cancer patients are 50 
years of age or older and often have other medical problems. In this age group quality of life 
is often the most important consideration in selecting treatment modality. It is desirable to 
avoid combining surgery and radiotherapy for the treatment of early primary tumours, and a 
choice must therefore be made between the two modalities.
For some sites (floor of the mouth, oral tongue), primary surgical resection is preferred 
because it reduces the risk of radiation complications while for other sites (retromolar 
trigone, gingiva, buccal mucosa, hard palate) radiotherapy is preferred because of its greater 
efficacy (40).
Although used less frequently than in the past, radiotherapy still has a role for patients with 
early primary lesions of the oral cavity if the patient refuses surgery or is medically 
inoperable. In these cases, the radiation oncologist must have the technical capability and 
knowledge of the appropriate time dose factors necessary to produce cure with a minimum 
of complications.
Most primary lesions of the retromolar trigone, whether early or advanced, are currently 
managed by resection initially. Radiotherapy is relatively unsuccessful in the control of 
retromolar trigone tumours when used exclusively. A combined-modality approach 
increases the five-year survival rates and offers better locoregional control and disease free 
survival (19;41).
After review of the pathologic specimen, patients may receive postoperative radiotherapy if 
certain adverse histological featui’es are detected (positive margins, close (<0.5 cm) margins, 
dysplasia or carcinoma in situ at the margins, vascular space invasion, perineural invasion, 
bone invasion, extension into the soft tissues of the neck, involvement of multiple lymph
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nodes (especially with multiple levels of involvement), or extracapsular extension from 
lymph node métastasés).
Preoperative radiotherapy is given when the patient has a fixed neck node or if the primary 
cancer extensively involves the dermal lymphatics, which have no valves and therefore may 
allow spread of cancer in many directions. Radiotherapy may also be used in palliation.
Radiotherapy Technique
Small lesions of the retromolar trigone may be managed by intraoral cone radiotherapy for 
all or part of the therapy. Well-lateralized lesions of the retromolar trigone may be treated by 
ipsilateral mixed beam techniques. An intraoral lead shield reduces the radiation dose given 
to the contralateral mucosa.
Patients receiving radical postoperative radiotherapy at Canniesburn Hospital were 
prescribed 60 Gy in 30 fractions over 6 weeks, commencing within 6-8 weeks of surgery. 
The oral cavity and anterior triangles of the neck were treated using a half-beam 
arrangement (42). The oral cavity was treated where possible using a wedged pair to spare 
the contralateral parotid and minimize long-term xerostomia.
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Materials and Methods
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Cadaver Preparation
Bodies donated to the Department of Anatomy at Glasgow University are routinely 
embalmed tlirough the carotid artery with a commercial embalming fluid. By modifying 
dissections described in “Cumiingham’s Manual of Practical Anatomy” (43), “Grant’s Atlas 
of Anatomy” (44) and “A new system of Anatomy” (45) and employing standard dissection 
techniques and instruments the gross anatomy of the RMT and surrounding areas were 
revealed. The author used forceps, scalpels with size 23 and 15 blades, and a small pair of 
scissors, available in any basic dissection kit. The specimen was dissected in layers, 
beginning with the removal of the mucosa.
It was decided that the excision of a T2 sized tumour would be the most appropriate 
operation to imitate, as this is the most common size of a tumour. T2 tumours are 2-4cm in 
diameter. The tumour site was marked on the RMT with a black marker pen. The resection 
margins were marked with a purple marker pen; approximately 1cm all round the 
pseudotumour (see Figure 17). The head was split in half with a power saw. The aim of this 
dissection was to find out the anatomic structures in danger when performing a retromolar 
trigone tumor excision.
Photographs were taken using a digital camera, Nikon Coolpix 990. The photographs were 
processed in Adobe Photoshop 6.0.
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Figure 17 T2 sized ‘Pseudotumour’ marked in black ink; Resection margin marked in purple 
ink
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Retrospective case  analysis
The Oral Pathology Unit in Glasgow Dental Hospital and School maintains a disease index 
of reported cases. From this it was possible to retrieve the pathology numbers of cases 
diagnosed as oral squamous cell carcinomas that were received and reported between 1st 
January 1985 and 31st December 1999. From the case numbers retrieved, it was possible to 
obtain the pathology report form of each case and this provided the name of the patient and 
the hospital record numbers. Having this information it was possible to look at the patient 
name index, as for each patient a separate card with all the related pathology report numbers 
is maintained. Thus it was possible to access all the pathology reports related to individual 
patients. Having the hospital numbers of these patients, their medical records were retrieved 
from Camiiesburn’s Medical Records Department.
The criteria used to include patients in this study were strict, demanding many times an 
arbitrary decision as to the site of origin, particularly with large lesions involving many 
adjacent sites. Large lesions involving many adjacent sites were included in the study if the 
epicenter of the lesion was in the retromolar trigone. Patients with lesions invading the 
retromolar trigone area from adjacent sites were excluded. The patients were included if they 
were previously untreated, had a biopsy proven squamous cell carcinoma reviewed by our 
pathologist and the minimum follow up was 2 years.
From a database of 1404 cases diagnosed as oral squamous cell carcinoma, 199 had the 
retromolar trigone area involved. From these patients only 113 fulfilled the above mentioned 
criteria. From these 113 patients with histologically proven squamous cell carcinoma of the 
retromolar' trigone, treated at Canniesburn Hospital, Glasgow between 1985 and 1999, the 
clinical presentation, therapy, pathological staging, patterns of loco-regional and systemic 
failure and survival were retrospectively analyzed. All the data were input and processed in 
a specially designed software application for Head and Neck, called Infoflex by Caméléon.
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The follow-up period ranged between 2 and 10 years. Ten patients with inadequate follow- 
up data and patients who died of unielated causes during the follow-up period were included 
in the survival analysis up to the time of their loss to follow-up or death and excluded 
thereafter, according to the Kaplan-Meier method. Five patients who underwent palliation 
only as the treatment modality were excluded from the survival analysis.
Statistical analysis was performed by using the SPSS for windows, version 10.1, computer 
program (SPSS Inc, Chicago,IL). The probabilities of determinate 5-year survival rates were 
calculated by the Kaplan-Meier method. To test the statistical significance of differences 
between curves, the log-rank test was used. The statistically significance correlation 
between length of symptoms and T stage of tumour was evaluated by using Kendall's rank 
correlation coefficient tau-b ( t )  test. A significance level of .05 was used for all statistical 
tests.
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Results
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Anatomy
Figure 18, Figure 19 and Figure 20 demonstrate the gross anatomy of the RMT and 
surrounding region. Superior to the RMT, forming the roof of the oral cavity is the hard and 
soft palate. Laterally is the buccal mucosa and medially the tonsillar fossa, the floor of the 
mouth and the posterolateral part of tongue.
Hard Palate Retromolar Trigone goft Palate
Buccal mucosa Floor of mouth Tongue
Figure 18 Retromolar trigone area (shadowed area).
After stripping the mucosa, the buccinator muscle and the superior constrictor of the 
pharynx connected with the pterygomanbibular raphe came into sight. The buccopharyngeal 
fascia lay immediately below the buccinator muscle and the superior constrictor of the 
pharynx separating them from the buccal pad of fat. Deeper dissection revealed the masseter
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muscle and the anterior border of the ascending ramus, almost all of which were invested by 
the tendinous insertion of the temporalis muscle. Crossing this border was the buccal nerve. 
Medially lay the anterior edge of the medial pterygoid muscle. In the acute deep angle 
formed by the medial pterygoid and the ascending ramus, which is open superiorly, ran the 
two branches of the mandibular nerve - the inferior alveolar and the lingual nerve. These 
three nerves -  the buccal, inferior alveolar and lingual -  were all at risk in the usually 
required margins of a retromolar trigone tumour excision.
Mylohyoid m.
Temporalis
tendon Medial Pterygoid m. Lingual n.
Sublingual Submandibular I Hyoglossus m.
gland duct Hypoglossal n. Genioglossus m.
Figure 19 Gross anatomy of the Retromolar trigone.
Having removed the mucosa over the floor of mouth and reflecting genioglossus from its 
attachments on the mandible, this allowed an excellent view of the sublingual and
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submandibular gland with its duct. The submandibular duct is another structure that could be 
traumatised during excision of RMT tumors, especially the ones that invade the lateral floor 
of mouth.
Inferior Alveolar n.Masseter m. i Medial Pterygoid m.
Temporalis tendon Sphenomandibular Lingual n. ^ ligament
Figure 20 Gross anatomy of the Retromolar trigone.
The functional implications of damage to all of the above mentioned structures would be in 
terms of difficulties in speech, chewing and swallowing.
The oral stage of swallowing requires the action of the mylohyoid, styloglossus and intrinsic 
muscles of the tongue. Movements of the tongue are essential in deglutition. Goldie et al’s 
investigation showed damage is likely to palatoglossus at least, thereby restricting this
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movement (68). As the soft palate is often involved in tumour spread, removal inflicts upon 
patients the distressing sensation of food passing into the nasopharynx on swallowing. The 
pterygomandibular raphe links buccinator and the superior constrictor of the pharynx. 
Damage to it would interfere with the stability of these muscles and inliibit their function: 
superior constrictor in the phaiyngeal stage of swallowing; buccinator is important in 
chewing and bolus preparation.
Motor control of speech is thought to operate via an afferent feedback control loop, whereby 
the sensory fibres of the oral cavity relay information back to the speech areas of the brain. 
According to this theory, damage to these afferent fibres during surgery would have 
detrimental implications for the patient’s speech. Experiments have taken place in attempt to 
simulate such an event. Local anaesthetic was injected bilaterally along the medial surface of 
the mandible resulting in complete anaesthesia to touch and pain of the tongue, lower lip and 
surface tissues of the mandible. This was considered to be the sensory domains of the 
inferior alveolai* and lingual nerves. Subjects were then assessed for speech errors. Speech 
was found to be considerably distorted (this is supported by anecdotal evidence following 
visits to the dentist), however, subjects were generally able to compensate their speech to 
retain it at intelligible level (69). This correlates with the clinical picture seen in oral cancer 
patients postoperatively.
A clinical study by Goldie et a l, showed correlation between injuries caused at operation in 
the RMT compared with an objective oral function scale in terms of speech and swallowing 
(70). It was shown that clinical tumour size could be used to predict the extent of functional 
deficit that RMT cancer surgery produces.
Incisions in the RMT will cause injury to certain oral structures with likely functional 
consequences. Damage to medial pterygoid and palatoglossus muscles can create difficulties 
with swallowing and speech. Division of the lingual nerve will result in loss of sensation in
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the tongue, which can also affect oral function. Such alterations may be additional to those 
caused by anatomical distortion resulting from tumour excision and reconstruction.
The findings of cadaver dissections pose immediate concerns for surgeons operating in RMT 
area. Although cancer surgery often involves sacrificing tissue, care should be taken to 
preserve structures vital to the patient’s oral function without compromising oncological 
principles.
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Natural History
Epidemiology
This retrospective study comprises 113 patients with squamous cell carcinoma of the RMT 
treated at Canniesburn Hospital, Glasgow, between 1985 and 1999. Seventy-eight (69%) 
were males and 35 (31%) were females. The male to female ratio for the whole group of 
patients was 2.2:1.
The average age of patients was 65 years (range 37-90 years). The average age of males was 
63.5 years (range 37-90 years) and 66 years (range 47-88 years) for females. The age 
distribution of patients is shown in Figure 21.
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Figure 21 Age distribution of patients (n = 113).
Ninety-four percent were smokers (average one pack of cigarettes/day). From that 
percentage 20.5% were ex-smokers.
Thirty-one percent were heavy alcohol drinkers (more than 30 units per week).
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Of the 113 patients, 108 had a primary untreated squamous cell carcinoma of the retromolar 
trigone, while the remaining 5 had a second primary tumour in this area. The majority of the 
cases (91 patients) were referred to the Head and Neck Clinic of Canniesburn Hospital from 
a consultant (Dentist, ENT surgeon, Maxillofacial surgeon) within the Trust. The rest were 
referred directly from their General Practitioner.
75
Pathology
All 113 patients had histologically proven squamous cell carcinoma of the retromolar 
trigone area. Twenty-six had poorly differentiated carcinoma, 5 were moderately, 3 were 
well differentiated and one was undifferentiated. The degree of differentiation has been 
included in the pathology report from 1995 onwaids. The average tumour thickness was 
3 mm.
In 7 specimens out of 26 there was perineural invasion and in 12 out of 26 there was 
vascular/lymphatic invasion. Those last tumour prognostic factors were included in the 
pathology reports only in the last 3 years of the study.
The resected margins were clear (>5mm) in 64 cases, close (l-5mm) in 7 cases, involved in 
22 cases, while the remaining 20 patients (unknown) underwent diagnostic biopsy only or 
were initially treated with radiotherapy.
Of the whole group 71 patients (63%) had a clinically negative neck at presentation and 42 
patients (37%) had a clinically positive neck. The most commonly involved nodal group in 
the metastasis was level II. Eleven patients, all with positive nodes at levels I and/or II, had 
histologically positive nodes at levels III and IV. Only one patient with positive nodes at 
level I and II on the ipsilateral side, had contralateral node metastasis at level III. A total of 
85 patients (75%) had a neck dissection at the time of initial treatment of the primary (51 
were considered elective from a clinical point of view and 34 therapeutic). Of these 85 
patients, 45 (53%) proved to have pathologically involved lymph nodes at presentation.
Results regarding the pathologically staging of the tmnors are analysed in details in a 
following chapter
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Patterns of spread
The most common sites of extension of the cancer were to the soft palate in 48% (54/113) of 
cases, the tonsillar pillar in 39% (44/113), the lower gum, the buccal mucosa and the floor of 
mouth, each in 10% (12/113) of cases. Other areas involved were the posterolateral part of 
tongue, the posterolateral pharyngeal wall and the maxillary sinus. Seventy-two percent 
(82/113) of patients had at least one adjacent area involved, while 28% (31/113) had only 
the retromolar trigone involved. The overall incidence of pathologically proven cancer 
invading bone was 23% (26/113).
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Clinical Presentation and Diagnosis
Figure 22 & Figure 23 demonstrate the clinical presentation of a SCC of the RMT of two 
different patients presented at Canniesburn Hospital.
The commonest presenting symptom was pain (including pain in the local area, sore throat 
and otalgia) in 37% (42/113) of cases, followed by an intraoral mass or ulcer in 24% 
(27/113) and dysphagia in 16% (18/113) of cases. Trismus was the main presenting 
symptom in only 6 cases. Out of 3 patients complaining about a neck mass, only one had 
this as the only presenting symptom.
Figure 22 SCC of the left retromolar trigone.
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Figure 23 SCC of the left retromolar trigone.
The average duration of symptoms prior to presentation was 1 month for clinical T1 lesions 
(7? =77), 2 months for T2 lesions (n = 47), 3 months for T3 lesions (n = 18), 2 months for T4 
lesions (n=37) and overall 2 months (n = 113). There was no significant statistical 
correlation between length of symptoms and T stage of tumour (Kendall's tau-b (t)=0.17, P 
= 0.838).
The average time from diagnosis till surgery was approximately 3 weeks, while the average 
time from first seen in our hospital till surgery was 2 weeks.
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Staging
A total of 9.7% of patients were clinically staged as T l, 41.6% as T2, 16% as T3 and 32.7% 
asT4.
Post-surgical (pathological) staging according to UICC classification of patients after 
surgery performed at Canniesburn Hospital is shown in Table 10. In 23 patients the primary 
tumour was not staged pathologically. This included those undergoing palliation and 
radiotherapy only as the treatment modality.
The accuracy of clinical assessment of T stage compared to pathological staging is shown in 
Table 11. The primary tumour was upstaged in 15.5% of patients (14/90) and downstaged in 
11% (10/90).
Table 10 Post-surgical (pathological) staging of patients according to UICC classification
pN stage
NO N1 N2a N2b N2c X Total
PT pTl 13 0 0 0 0 1 14
stage
pT2 10 7 1 9 0 2 29
pT3 2 2 0 7 0 0 11
pT4 18 6 1 10 1 0 36
X 1 0 0 2 0 20 23
Total 44 15 2 28 1 23 113
Table 11 Accuracy of clinical T staging compared to pathological T staging according to 
UICC classification
Clinical T stage
Tl T2 T3 T4 Total
pT stage pTl 7 7 0 0 14
pT2 1 25 2 1 29
pT3 0 1 10 0 11
pT4 0 7 5 24 36
X 3 7 1 12 23
Total 11 47 18 37 113
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The accuracy of clinical assessment of neck nodes showed pathological upstaging of disease 
in 21% and downstaging in 9% (Table 12).
Table 12 Accuracy of clinical assessment of status of neck nodes
Clinical NO Clinical N +ve Total
Pathological NO 3 6 (True -ve) 8 (False +ve) 44
Pathological N +ve 19 (False -ve) 27(True +ve) 46
X 16 7 23
Total 71 42 113
False positive rate= 8/44 = 18%, Specificity=36/44= 82%. 
False negative rate= 19/46 = 41%, Sensitivity=27/46= 59%.
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Treatment protocol
The selection of treatment was determined in a non-randomized mamier. Throughout the 
study period the policy at this unit was to surgically excise the primary tumour if possible 
(41;46). Patients with a clinically positive neck underwent a therapeutic neck dissection and 
most of the patients with a clinically negative neck underwent elective neck dissection, for 
better access to the primary tumour, reconstruction requirements or cases deemed at high 
risk for developing cervical metastasis. Radiotherapy was given postoperatively depending 
on the bulk of the tumour, depth of infiltration, closeness of resection margins and a positive 
lymph node in the neck.
Exceptions to this treatment protocol included patients who refused surgery, those excluded 
for medical reasons, recurrence following previous treatment and cases treated for palliation. 
The treatment protocols are detailed in Table 13.
Table 13 Initial treatment protocol of primary site
Initial treatment protocol No. of patients (%)
Combined (surgery and 75 (66.4)
postoperative radiotherapy)
Surgery only 20 (17.8)
Radiotherapy only 8 (7)
Other (chemotherapy+/- 8 (7)
radiotherapy+/-sui'gery)
Supportive 2 (1.8)
Total 113 100
Management of the neck
A total of 85 patients (75%) had a neck dissection at the time of initial treatment of the 
primary (51 were considered elective from a clinical point of view and 34 therapeutic). Neck 
dissections(47) were radical in 19 cases, modified radical type I in 4, type II in 2, type III in
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48, selective levels I-III (supraomohyoid) in 3, selective levels I-IV (anterolateral) in 4 and 
‘not otherwise specified’ neck dissection in 10 cases.
Reconstruction
The defects were repaired with a free radial forearm flap in 71 patients (5 were 
osteocutaneous flaps), with pectoralis major muscle pedicled flap in 8, with buccal flaps in 8 
and with other flaps (nasolabial, temporalis muscle, deep circumflex iliac artery, lateral arm, 
ulnar, tongue flap) in 11 patients. In only one patient the defect was closed primarily. Figure 
24-28 show in stages the excision of a SCC of the RMT and the reconstruction of the defect 
with a free radial forearm flap. Figure 29-35 show in stages the excision of a SCC of the 
RMT and the reconstruction of the defect with a nasolabial flap.
Figure 24 Squamous Cell Carcinoma of left retromolar trigone
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Figure 25 Tumor excised with 1cm margins
Figure 26 The defect after the excision
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Figure 27 Design of free radial forearm flap
Figure 28 Insetting of the flap
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Figure 29 Squamous Cell Carcinoma of left retromolar trigone
Figure 30 Tumor excised with 1cm margins and marginal mandibulectomy
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Figure 31 SCC of left retromolar trigone
Figure 32 Design of a nasolabial flap
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Figure 33 The nasolabial flap raised
Figure 34 Passed through a tunnel
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Figure 35 Nasolabial flap inset
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Results of treatm ent
This study covers a period of 15 years from 1985 to 1999. The determinate 5-year survival 
rates related to pathological T stage according to UICC classification by the Kaplan-Meier 
method Avere pTl: 75%, pT2: 40%, pT3: 47%, pT4: 32% and overall 42% (logrank=7, 
d.f.=3, P= 0.071) (Figure 36 and Figure 37). Clinical T stage was used for patients whose 
primary tumour was not initially staged pathologically (n = 23).
Survival Analysis related to 
pT stage
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Figure 36 Corrected survival related to pT stage (UICC). Clinical T stage was used for 
patients whose primary tumour was not initially staged pathologically (n =23).
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Figure 37 Corrected overall survival.
The determinate 5-year survival rates related to pathological N stage according to UICC 
classification by the Kaplan-Meier method were pNO: 58%, pN l: 19%, pN2/3: 28% 
(logrank=9, d.f.=2, P=0.01) (Figure 38). Clinical N stage was used for patients whose 
primary tumour was not initially staged pathologically (n ^23).
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Figure 38 Corrected survival related to pN stage (UICC). Clinical N stage was used for 
patients whose primary tumour was not initially staged pathologically (n =23).
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The determinate sui'vival curves related to the status of lymph nodes found at initial neck 
dissection are shown in Figure 39. There was no statistically significant difference between 
patients with one or more than one positive lymph nodes (one vs more than one; 
logrank=0.42, T=0.517). On the other hand, patients with negative lymph nodes had a 
significant sui'vival advantage over patients with positive lymph nodes (pos vs neg; logrank 
=9, P = 0.027) (Figure 39).
Survival Analysis related to 
node status
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Figure 39 Corrected survival related to nodal status.
The determinate 5-year survival rates related to pathological TNM stage were stage I: 73%, 
stage II: 55%, stage III: 29% and stage IV 34% (logrank=5.18, d.f.=3, F=O.I58) (Figure 40).
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Survival Analysis related to 
pTNM stage
.9-
■m~m
V fis r*.i
CO
<3 DJO 3 6 T 8o
survival years
Figure 40 Corrected survival related to pTNM stage.
The determinate survival curves related to sex and age were studied and showed no 
statistically significant differences (male vs female logrank=0.36, P=0.548, and <65 years vs 
>65 years; logrank=0.52, f^O.472). The age group <65 years however did show a drop in 
survival rate compai'ed to the >65 years, which was not statistically significant (Figure 41).
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Figure 41 Corrected survival related to age.
The adequacy of resection margin for the primary tumour at the initial surgery as reported 
by the pathologist was: clear 64 patients, close (within 5mm of resection margin) 7 patients, 
involved 22 patients, while the remaining 20 patients (unknown) underwent diagnostic 
biopsy only or were initially treated with radiotherapy. The determinate survival curves for 
the three surgical groups were studied and showed statistically significant differences 
between them, regardless of any further treatment they may have received (clear v close; 
logrank = 7.13, P  = 0.007; clear v involved; logrank = 12.95, P = 0.0003) (Figure 412).
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Survival Analysis related to 
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Figure 412 Corrected survival related to resection margin of primary tumour found at initial 
surgery.
Other confounding factors for locoregional recurrence apart from close or positive surgical 
margins are (71):
• Nodal involvement: Nodal involvement affects prognosis adversely. Higher numbers 
and more inferior levels of nodes involved are adversely related to prognosis as is 
extracapsular spread
• T stage: Higher T stage correlates with poorer prognosis.
• Depth of invasion: Tumour thickness of greater than 4 mm imparts a worse 
prognosis.
• Vascular and perineural infiltration: Perineural infiltration is a sensitive predictor of 
local recurrence and prognosis.
Tumor grade: a higher grade equates to a poorer prognosis.
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• Pattern of infiltration: A non-cohesive, infiltrative pattern of growth, as opposed to a 
cohesive pattern with broad strands and sheets of tumour, is related to a poorer 
outcome.
• Tumour type: Papillary and verrucous carcinomas generally have a better prognosis, 
whilst basaloid and spindle cell variants behave more aggressively.
The loco-regional failure and site failure considered to have been the cause of eventual 
demise of patients is shown in Table 14 and Table 15. In all, 38 patients (33.6%) died of 
disease directly related to the retromolar trigone cancer or its treatment while 29 patients 
(25.6%) died of unrelated conditions during the follow-up period. Systemic failure 
accounted for 14 patients out of 113 (12.4%). The most common distant métastasés were to 
the lungs and liver. A total of 32% of patients in this study remain alive and well (Table 16).
Table 14 The loco-regional and systemic failure rates
Recurrence site Tl
(n= ll)
T2
(n=47)
T3/4
(n=55)
Total (%) 
(n=113)
Lost to follow-up 2 4 4 10(8.8)
No recurrence 7 35 43 85(75)
Primary site 2 8 9 19(16.8)
Ipsilateral neck 0 0 0 0(0)
Contralateral neck 0 1 0 1(0.8)
Primary site and neck 0 1 4 5(4.4)
Second intraoral primary 1 0 0 1(0.8)
Systemic 2 2 10 14(12.4)
N.B. Some patients had more than one recurrence.
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Table 15 Site failure leading to eventual demise
Tl
(n= ll)
T2
(n=47)
T3/4
(n=55)
Total (%) 
(n=113)
Lost to follow-up 2 4 4 10(8.8)
Palliated 0 0 5 5(4.4)
Primary site 1 8 9 18(16)
Ipsilateral neck 0 0 0 0(0)
Contralateral neck 0 1 0 1(0.8)
Primary site and neck 0 1 4 5(4.4)
Second intraoral primary 0 0 0 0(0)
Systemic 2 2 10 14(12.4)
Incidental deaths 0 14 15 29(25.6)
Alive and well 6 17 13 36(31.8)
N.B. Some patients had more than one recurrence.
Table 16 Cause of death
Cause of death No. o f  patients (%)
Disease related 38(33.6)
Incidental 29(25.6)
Lost to follow-up 10 (8.8)
Alive and well 36 (32)
Total 113 (100)
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Discussion
Retromolar trigone cancer is an unusual oral cancer. Its natural history is not well known 
and is frequently compared with that of inferior gingival or anterior tonsillar pillar cancers 
(17;48-50). The natural history and patterns of treatment failure of retromolar trigone 
carcinoma treated in a single head and neck unit have been studied over a period of 15 years. 
No comparison was made between different modalities of treatment in this series because 
patients were not randomly assigned to a particulai' treatment modality. By far the majority 
(84%) was managed by surgical excision alone or combined with postoperative 
radiotherapy.
The anatomic location and the propensity for tumors of this region to invade adjacent 
structures (base of tongue, tonsil, palate) explains why accessibility for excision and 
reconstruction is difficult. Only early lesions of the RMT can be resected transorally and 
reconstruction can be achieved with a local advancement flap, split thickness skin graft, or 
healing by secondary intention. Larger tumors require increased exposure which can be 
achieved tlii'ough a mandibulotomy. Resection of such an RMT tumour, as demonstrated 
from cadaveric dissection, is likely to cause injury to the lingual nerve, the inferior alveolar 
nerve, the submandibular duct and several muscles of the oral cavity. The functional 
implications would be in terms of difficulties in speech, chewing and swallowing. The 
efficacy of local advancement flaps and adjacent tissue transfer for reconstruction is often 
limited in this area either because the tissue is irradiated or because the available tissue is 
limited. Free tissue transfer is often the only reconstructive option that can achieve optimal 
functional results. Thin pliable fascial flaps that can mould into various contours, such as the 
radial foreaim free flap, can be used to resurface the defect.
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Our data analysis confirms results that have been published by others (17;48;49). Our series 
however has a higher incidence of women presenting with carcinoma of the retromolar 
trigone (male: female ratio 13:1 published in 1959 by Barbosa, 10:1 published in 1993 by 
Kowalski et al, 2.2:1 published by our series) (17;48), most likely explained by the increased 
incidence of smoking and drinking among women in recent decades. We have found no 
statistically significant difference in survival between the different age groups. In our series, 
although the group of patients younger than 65 years old had a worse outcome (5-year 
survival 37%) compared with the older group (5-year survival 48%), the difference failed to 
reach statistical significance. Interestingly enough the same result was published by 
Kowalski, regarding patients younger than 56 years old having a worse 5-year survival (17). 
Maybe this is an indication that the cancer might be more aggressive in younger patients.
We have not demonstrated any correlation between the average duration of symptoms and T 
stage, perhaps demonstrating the unreliability of patients’ assessment of the presence of 
disease.
The 5-year overall survival in our series was 42%, which is higher than 20% that Byers et al
(49) reported in their series of 110 patients but lower than 55.3% that Kowalski reported 
(17) in his series of 114 patients. Further statistical work could be carried out to evaluate the 
5-year local control rates, 5-year local-regional control rates, 5-year distant metastasis-free 
survival rates and 5-year cause-specific survival rates. Multivariate analyses could be earned 
out to reveal significant predictors for locoregional and systemic failure.
The control of carcinoma of the retromolar trigone is closely related to the extent of the 
primary tumour and the state of the regional lymph nodes. Metastasis to regional and 
cem cal nodes is reported in 40 to 60% of the cases (51). The frequency (41%) and 
distribution of lymph node métastasés in this series were similar to those reported by others 
(17;49;52). This series has demonstrated a significant survival advantage for patients with
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node negative disease (58% 5-year survival) and a significantly poorer outcome for patients 
with positive nodes (25% 5-year suiwival). In the group of patients with positive nodes, 
patients with only one positive node had similar survival rate compaied with patients with 
more than one positive lymph nodes.
We have also been able to study the clinical accuracy of staging in an experienced head and 
neck unit. Pathology upstaged the primary tumour in 15.5% of patients (14/90) and 
downstaged in 11% (10/90). In the staging of neck disease, pathology upstaged 21% of 
clinically NO necks and downstaged 9% of clinical N +ve disease. Kowalski et al have also 
reported a high incidence of false clinical diagnosis of the status of cervical lymph nodes
(17).
The importance of achieving a clear resection margin at the first surgery cannot be 
overemphasized as survival is closely related to resection margin regardless of any 
subsequent therapy the patients may receive.
The natural history of squamous cell cai cinoma is of loco-regional failure and our results are 
comparable to previous reports. Of the patients in this series 34% (38/113) died as a result of 
their retromolar trigone cancer or its treatment. Systemic failure accounted for 12.4% of 
deaths, further emphasizing the need to obtain better loco-regional control of disease.
A total of 32% of patients in this series remain alive and well, while 21% died of local or 
regional disease. Byers et al reported ultimate failure in the primary site in 7% and at the 
neck in 11% of the patients with retromolar trigone cancer (49). Kowalski found that most 
recurrences are local and usually seen in the first 2 years of follow-up (17). Our analysis 
confirms these results. In our series the average time from the date of treatment to recurrence 
was 45.6 weeks and 94.4% of the recurrences occurred in less than 64 weeks of follow-up. 
Problems with the correct staging of disease for retromolar' trigone carcinoma are clearly 
demonstrated. This applies both to the T stage and particularly to nodal metastasis. More
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accurate methods of staging the disease at the primary site and in the neck are required so 
that suitable treatment protocols can be adopted with the aim of improving control of disease 
and overall survival. This review covers patients treated from 1985 until 1999 at which time 
CT and MRI scanning was not used to any great extent at Canniesburn Hospital. Over the 
last years these tecliniques have become very important in assessing the tumour, assisting in 
the staging of the tumour and in helping the decision process regarding overall management.
The understanding of the natural history of retromolar trigone tumours as a separate entity 
from other intraoral squamous cell carcinomas allows us to give more accurate infonnation 
about prognosis for patients presenting with squamous cell carcinoma of the retromolar 
trigone. It also allows us to formulate different strategies for its treatment.
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statement
My research work so far, has been presented at the winter meeting of the British Association 
of Plastic Surgeons (B.A.P.S.) in London, UK, 27-30 November 2002 and submitted for 
publication to the Journal of Plastic, Reconstructive & Aesthetic Surgery (manuscript 
number: JPRAS-D-07-00075).
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